Skip to main content
Clinical Trials/PACTR201311000700893
PACTR201311000700893
Not yet recruiting
未知

Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia (4P) ¿ a randomised, placebo-controlled, double-blind clinical trial.

niversity Medical Center Utrecht0 sites440 target enrollmentNovember 8, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Circulatory System
Sponsor
niversity Medical Center Utrecht
Enrollment
440
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • \<16 weeks of gestation and over 18 years of age,
  • \- Intention to have subsequent antenatal visits and delivery at the same clinic.
  • \- Can receive text messages by phone or through the phone of a proxy.
  • \- A moderate to high risk (\>20%) of developing PIH

Exclusion Criteria

  • \- Pre\-existing hypertension or hypertension before 20 weeks gestation.
  • \- Likely non\-compliance with the protocol in view of the treating physician
  • \- Comorbidity interfering with the protocol
  • \- Known contraindications to Investigational Product components

Outcomes

Primary Outcomes

Not specified

Similar Trials